2020 Q4 Form 10-Q Financial Statement

#000157694020000065 Filed on October 29, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $987.8M $794.4M $590.4M
YoY Change 24.64% 34.55% 5.1%
Cost Of Revenue $752.9M $629.4M $474.5M
YoY Change 18.62% 32.64% 2.88%
Gross Profit $234.9M $165.0M $115.9M
YoY Change 48.86% 42.36% 15.32%
Gross Profit Margin 23.78% 20.77% 19.63%
Selling, General & Admin $95.60M $85.81M $72.83M
YoY Change 13.14% 17.81% 2.62%
% of Gross Profit 40.7% 52.0% 62.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.000M $3.300M $3.600M
YoY Change -16.67% -8.33% 9.09%
% of Gross Profit 1.28% 2.0% 3.11%
Operating Expenses $95.60M $85.81M $72.83M
YoY Change 13.0% 17.81% 2.62%
Operating Profit $139.3M $79.19M $43.07M
YoY Change 90.3% 83.89% 45.86%
Interest Expense -$1.000M -$800.0K -$600.0K
YoY Change 66.67% 33.33% 50.0%
% of Operating Profit -0.72% -1.01% -1.39%
Other Income/Expense, Net -$16.60M $251.0K -$56.00K
YoY Change 19.42% -548.21% -89.72%
Pretax Income $121.2M $64.89M $34.84M
YoY Change 124.51% 86.24% 52.41%
Income Tax $29.30M $15.10M $7.800M
% Of Pretax Income 24.18% 23.27% 22.39%
Net Earnings $91.82M $49.76M $27.02M
YoY Change 72.08% 84.15% 58.52%
Net Earnings / Revenue 9.3% 6.26% 4.58%
Basic Earnings Per Share $2.75 $1.49 $0.88
Diluted Earnings Per Share $2.72 $1.48 $0.87
COMMON SHARES
Basic Shares Outstanding 33.35M 33.35M 30.59M
Diluted Shares Outstanding 33.73M 30.91M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $394.0M $288.3M $38.50M
YoY Change 611.19% 648.83% 142.14%
Cash & Equivalents $394.0M $288.3M $38.51M
Short-Term Investments
Other Short-Term Assets $18.70M $21.50M $29.30M
YoY Change -28.63% -26.62% 38.21%
Inventory $1.930B $1.872B $2.094B
Prepaid Expenses
Receivables $21.80M $28.90M $17.90M
Other Receivables $2.400M $2.400M $2.700M
Total Short-Term Assets $2.367B $2.213B $2.182B
YoY Change 12.32% 1.44% 14.54%
LONG-TERM ASSETS
Property, Plant & Equipment $28.38M $31.55M $35.26M
YoY Change -21.15% -10.52% 7.41%
Goodwill $30.40M $30.40M $30.40M
YoY Change 0.0% 0.0% -0.73%
Intangibles $4.094M
YoY Change -21.34%
Long-Term Investments
YoY Change
Other Assets $39.70M $41.60M $47.70M
YoY Change -18.98% -12.79% 3.47%
Total Long-Term Assets $478.5M $378.0M $307.7M
YoY Change 21.8% 22.85% 24.26%
TOTAL ASSETS
Total Short-Term Assets $2.367B $2.213B $2.182B
Total Long-Term Assets $478.5M $378.0M $307.7M
Total Assets $2.845B $2.591B $2.490B
YoY Change 13.81% 4.09% 15.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $107.7M $48.40M $78.70M
YoY Change 27.0% -38.5% 93.84%
Accrued Expenses $233.7M $288.7M $199.6M
YoY Change 9.41% 44.64% 12.77%
Deferred Revenue
YoY Change
Short-Term Debt $259.1M $173.4M $77.80M
YoY Change 48.82% 122.88% 35.78%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $603.6M $510.5M $356.1M
YoY Change 27.66% 43.36% 29.54%
LONG-TERM LIABILITIES
Long-Term Debt $894.9M $895.9M $1.175B
YoY Change -7.3% -23.76% 14.81%
Other Long-Term Liabilities $65.90M $7.200M
YoY Change -45.86%
Total Long-Term Liabilities $960.8M $895.9M $1.182B
YoY Change -0.48% -24.22% 14.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $603.6M $510.5M $356.1M
Total Long-Term Liabilities $960.8M $895.9M $1.182B
Total Liabilities $1.564B $1.406B $1.538B
YoY Change 8.77% -8.58% 17.28%
SHAREHOLDERS EQUITY
Retained Earnings $583.2M $491.4M $323.7M
YoY Change 54.68% 51.81% 36.09%
Common Stock $697.5M $693.6M $627.5M
YoY Change 1.88% 10.53% 4.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.281B $1.185B $951.2M
YoY Change
Total Liabilities & Shareholders Equity $2.845B $2.591B $2.490B
YoY Change 13.81% 4.09% 15.66%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $91.82M $49.76M $27.02M
YoY Change 72.08% 84.15% 58.52%
Depreciation, Depletion And Amortization $3.000M $3.300M $3.600M
YoY Change -16.67% -8.33% 9.09%
Cash From Operating Activities $24.80M $142.0M -$56.00M
YoY Change -69.08% -353.57% -58.85%
INVESTING ACTIVITIES
Capital Expenditures -$1.800M -$1.800M -$5.300M
YoY Change -60.0% -66.04% 20.45%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$1.800M -$1.700M -$5.400M
YoY Change -33.33% -68.52% 20.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 84.20M -26.30M 68.20M
YoY Change -239.17% -138.56% -49.96%
NET CHANGE
Cash From Operating Activities 24.80M 142.0M -56.00M
Cash From Investing Activities -1.800M -1.700M -5.400M
Cash From Financing Activities 84.20M -26.30M 68.20M
Net Change In Cash 107.2M 114.0M 6.800M
YoY Change 530.59% 1576.47% -258.14%
FREE CASH FLOW
Cash From Operating Activities $24.80M $142.0M -$56.00M
Capital Expenditures -$1.800M -$1.800M -$5.300M
Free Cash Flow $26.60M $143.8M -$50.70M
YoY Change -68.6% -383.63% -61.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Central Index Key
EntityCentralIndexKey
0001576940
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
CY2020Q3 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
CY2020Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36491
dei Entity Registrant Name
EntityRegistrantName
Century Communities, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
68-0521411
dei Entity Address Address Line1
EntityAddressAddressLine1
8390 East Crescent Parkway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 650
dei Entity Address City Or Town
EntityAddressCityOrTown
Greenwood Village
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80111
dei City Area Code
CityAreaCode
303
dei Local Phone Number
LocalPhoneNumber
770-8300
dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
CCS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33350633
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
288341000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55436000
CY2020Q3 ccs Cash Held In Escrow
CashHeldInEscrow
26275000
CY2019Q4 ccs Cash Held In Escrow
CashHeldInEscrow
35308000
CY2020Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
28855000
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
27438000
CY2020Q3 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
1872337000
CY2019Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
1995549000
CY2020Q3 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
187494000
CY2019Q4 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
185246000
CY2020Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
113339000
CY2019Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
124008000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31550000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35998000
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12775000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10589000
CY2020Q3 us-gaap Goodwill
Goodwill
30395000
CY2019Q4 us-gaap Goodwill
Goodwill
30395000
CY2020Q3 us-gaap Assets
Assets
2591361000
CY2019Q4 us-gaap Assets
Assets
2499967000
CY2020Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
48448000
CY2019Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
84794000
CY2020Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
288674000
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
213975000
CY2020Q3 us-gaap Notes Payable
NotesPayable
895867000
CY2019Q4 us-gaap Notes Payable
NotesPayable
896704000
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
68700000
CY2020Q3 ccs Mortgage Repurchase Facility
MortgageRepurchaseFacility
173415000
CY2019Q4 ccs Mortgage Repurchase Facility
MortgageRepurchaseFacility
174095000
CY2020Q3 us-gaap Liabilities
Liabilities
1406404000
CY2019Q4 us-gaap Liabilities
Liabilities
1438268000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33350633
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33350633
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33067375
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33067375
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
334000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
331000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
693269000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
684354000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
491354000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
377014000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1184957000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1061699000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2591361000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2499967000
CY2020Q3 us-gaap Revenues
Revenues
794361000
CY2019Q3 us-gaap Revenues
Revenues
590362000
us-gaap Revenues
Revenues
2173414000
us-gaap Revenues
Revenues
1743369000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
85806000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72834000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
246131000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
216987000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10832000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1691000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
251000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-56000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2533000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-499000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
64885000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
34840000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
149076000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
78667000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15121000
us-gaap Net Income Loss
NetIncomeLoss
114340000
us-gaap Net Income Loss
NetIncomeLoss
59636000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.49
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7816000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34736000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19031000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
49764000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
27024000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.96
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.48
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.87
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.95
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33350633
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30587487
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33299768
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30378860
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33731252
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30906235
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33556650
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30641194
us-gaap Net Income Loss
NetIncomeLoss
114340000
us-gaap Net Income Loss
NetIncomeLoss
59636000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10088000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9793000
us-gaap Share Based Compensation
ShareBasedCompensation
14374000
us-gaap Share Based Compensation
ShareBasedCompensation
11391000
ccs Fair Value Of Loans Held For Sale And Other
FairValueOfLoansHeldForSaleAndOther
-9346000
ccs Fair Value Of Loans Held For Sale And Other
FairValueOfLoansHeldForSaleAndOther
-87000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10832000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1691000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2186000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-514000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1213000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-846000
ccs Increase Decrease In Cash Held In Escrow
IncreaseDecreaseInCashHeldInEscrow
-9033000
ccs Increase Decrease In Cash Held In Escrow
IncreaseDecreaseInCashHeldInEscrow
6018000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1417000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4465000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-160877000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
215771000
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
594000
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-17073000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-18090000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-32386000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-36346000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11212000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
35989000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-52854000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
315806000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-148964000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6706000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11633000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-79000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-78000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6627000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11555000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
678000000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1184800000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
746700000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1108500000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
500000000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
391942000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5469000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
12629000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7259000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
19275000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6075000
ccs Proceeds From Repayments Of Mortgage Credit Facility
ProceedsFromRepaymentsOfMortgageCreditFacility
-680000
ccs Proceeds From Repayments Of Mortgage Credit Facility
ProceedsFromRepaymentsOfMortgageCreditFacility
-26757000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25817000
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
5145000
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
3588000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1439000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-495000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-76810000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
165670000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
232369000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5151000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58521000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36441000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
290890000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41592000
us-gaap Income Taxes Paid
IncomeTaxesPaid
30998000
us-gaap Income Taxes Paid
IncomeTaxesPaid
20722000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
288341000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38508000
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
2549000
CY2019Q3 us-gaap Restricted Cash
RestrictedCash
3084000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-81000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
290890000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41592000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1129488000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5786000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
49764000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1184957000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
897229000
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23154000
CY2019Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
151000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3923000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
27024000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
951179000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1061699000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-311000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
5145000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14374000
us-gaap Net Income Loss
NetIncomeLoss
114340000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1184957000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
859359000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25817000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1439000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3585000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11391000
us-gaap Net Income Loss
NetIncomeLoss
59636000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
951179000
CY2020Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
17
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5
us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Use of Estimates</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates, particularly given the uncertainties associated with the ongoing COVID-19 pandemic.</span>
CY2020Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
17
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5
CY2020Q3 us-gaap Revenues
Revenues
794361000
CY2019Q3 us-gaap Revenues
Revenues
590362000
us-gaap Revenues
Revenues
2173414000
us-gaap Revenues
Revenues
1743369000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
64885000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
34840000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
149076000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
78667000
CY2020Q3 us-gaap Assets
Assets
2591361000
CY2019Q4 us-gaap Assets
Assets
2499967000
CY2020Q3 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
980232000
CY2019Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
1091576000
CY2020Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
825779000
CY2019Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
836904000
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
66326000
CY2019Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
67069000
CY2020Q3 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
1872337000
CY2019Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
1995549000
CY2020Q3 us-gaap Participating Mortgage Loans Mortgage Obligations Amount
ParticipatingMortgageLoansMortgageObligationsAmount
193100000
CY2019Q4 us-gaap Participating Mortgage Loans Mortgage Obligations Amount
ParticipatingMortgageLoansMortgageObligationsAmount
37600000
CY2020Q3 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
187500000
CY2019Q4 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
185200000
CY2020Q3 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
179900000
CY2019Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
179300000
CY2020Q3 us-gaap Prepaid Insurance
PrepaidInsurance
21537000
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
26175000
CY2020Q3 ccs Lot Option And Escrow Deposits
LotOptionAndEscrowDeposits
36828000
CY2019Q4 ccs Lot Option And Escrow Deposits
LotOptionAndEscrowDeposits
48810000
CY2020Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3550000
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4574000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2549000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3085000
CY2020Q3 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
2460000
CY2019Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
2602000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16697000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18854000
CY2020Q3 us-gaap Other Assets
OtherAssets
22308000
CY2019Q4 us-gaap Other Assets
OtherAssets
18525000
CY2020Q3 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
7410000
CY2019Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
1383000
CY2020Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
113339000
CY2019Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
124008000
CY2020Q3 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
25721000
CY2019Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
10592000
CY2020Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12890000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
9731000
CY2020Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
39713000
CY2019Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
30888000
CY2020Q3 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
149842000
CY2019Q4 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
110284000
CY2020Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
16211000
CY2019Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
19306000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
17155000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
14562000
CY2019Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
329000
CY2020Q3 us-gaap Other Liabilities
OtherLiabilities
27142000
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
18283000
CY2020Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
288674000
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
213975000
CY2019Q3 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-600000
us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-1300000
us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-400000
CY2020Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11221000
CY2019Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
9768000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
9731000
CY2018Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
7970000
CY2020Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2293000
CY2019Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1665000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
6345000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
5433000
CY2020Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
624000
CY2019Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
870000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1925000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
3063000
CY2019Q3 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-573000
us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-1261000
us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-350000
CY2020Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12890000
CY2019Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
9990000
CY2020Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12890000
CY2019Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
9990000
CY2020Q3 us-gaap Notes Payable
NotesPayable
895867000
CY2019Q4 us-gaap Notes Payable
NotesPayable
896704000
CY2020Q3 ccs Mortgage Repurchase Facility
MortgageRepurchaseFacility
173415000
CY2019Q4 ccs Mortgage Repurchase Facility
MortgageRepurchaseFacility
174095000
CY2020Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
1069282000
CY2019Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
1139499000
CY2020Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
70311000
CY2019Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
63068000
CY2019Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
67069000
CY2018Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
53842000
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
15065000
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
19325000
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
50686000
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
55792000
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
19050000
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
14258000
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
51429000
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
41499000
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
66326000
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
68135000
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
66326000
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
68135000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.234
us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.001
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15100000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7800000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34700000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000000.0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1700000
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5800000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3900000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14400000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11400000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000.0
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000.0
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000.0
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000.0
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33400000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33400000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33100000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33100000
CY2018Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
4500000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
83000
CY2019Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
83000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1400000
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1400000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
49764000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
27024000
us-gaap Net Income Loss
NetIncomeLoss
114340000
us-gaap Net Income Loss
NetIncomeLoss
59636000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33350633
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30587487
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33299768
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30378860
CY2020Q3 ccs Incremental Common Shares Attributable To Restricted Stock Units Outstanding
IncrementalCommonSharesAttributableToRestrictedStockUnitsOutstanding
380619
CY2019Q3 ccs Incremental Common Shares Attributable To Restricted Stock Units Outstanding
IncrementalCommonSharesAttributableToRestrictedStockUnitsOutstanding
318748
ccs Incremental Common Shares Attributable To Restricted Stock Units Outstanding
IncrementalCommonSharesAttributableToRestrictedStockUnitsOutstanding
256882
ccs Incremental Common Shares Attributable To Restricted Stock Units Outstanding
IncrementalCommonSharesAttributableToRestrictedStockUnitsOutstanding
262334
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33731252
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30906235
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33556650
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30641194
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.49
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.96
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.48
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.87
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.95
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000
CY2020Q3 ccs Land Development Performance Obligations Letters Of Credit And Performance Bonds
LandDevelopmentPerformanceObligationsLettersOfCreditAndPerformanceBonds
360100000
CY2019Q4 ccs Land Development Performance Obligations Letters Of Credit And Performance Bonds
LandDevelopmentPerformanceObligationsLettersOfCreditAndPerformanceBonds
344100000

Files In Submission

Name View Source Status
0001576940-20-000065-index-headers.html Edgar Link pending
0001576940-20-000065-index.html Edgar Link pending
0001576940-20-000065.txt Edgar Link pending
0001576940-20-000065-xbrl.zip Edgar Link pending
ccs-20200930.xsd Edgar Link pending
ccs-20200930x10q.htm Edgar Link pending
ccs-20200930x10q_htm.xml Edgar Link completed
ccs-20200930xex22_1.htm Edgar Link pending
ccs-20200930xex31_1.htm Edgar Link pending
ccs-20200930xex31_2.htm Edgar Link pending
ccs-20200930xex31_3.htm Edgar Link pending
ccs-20200930xex32_1.htm Edgar Link pending
ccs-20200930xex32_2.htm Edgar Link pending
ccs-20200930xex32_3.htm Edgar Link pending
ccs-20200930_cal.xml Edgar Link unprocessable
ccs-20200930_def.xml Edgar Link unprocessable
ccs-20200930_lab.xml Edgar Link unprocessable
ccs-20200930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending